×

CellRapeutics™ Leukopak from Hypertension Donor (XS-0426-XU282)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Procured from donors with Essential Hypertension, this Leukopak reflects the systemic immune adaptations to chronic hemodynamic stress. The cellular profile features activated T-cell subsets and monocytes linked to the renin-angiotensin-system-mediated inflammation. This biofluid is vital for investigating the role of circulating leukocytes in arterial stiffening and the secondary target-organ damage associated with high blood pressure.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ Leukopak from Hypertension Donor
  • Cat. No.
  • XS-0426-XU282
  • Donor Age
  • Middle-Aged, Senior
  • Donor Health
  • Clinically diagnosed with chronic Hypertension. Leukocytes exhibit markers of systemic vascular strain and potential RAAS-mediated immune activation signatures within the circulating myeloid compartment.
  • Ethnicity
  • Diverse backgrounds available.
  • Anticoagulant
  • Acid Citrate Dextrose, standard formulation optimized to maintain leukocyte integrity under varying shear stress conditions.
  • Additional Donor Information
  • Each lot features a Leukopak from donors with primary hypertension. Profiles include blood pressure management history and BMI, supporting research into the role of innate and adaptive immunity in vascular resistance.
  • Clinical Profile
  • Classification, duration of condition, average blood pressure readings, and history of anti-hypertensive medication classes.

Additional Information

  • Medication History
  • Available upon request. Documentation of long-term use of ACE inhibitors, ARBs, Beta-blockers, Calcium channel blockers, or diuretics for blood pressure management.
  • Formulation
  • Cryopreserved or Fresh options available.
  • Cell Purity
  • >90%
  • Cell Viability
  • >90%
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Genetic Stability Testing
  • The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.
  • Storage
  • Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • Full Bag, Half Bag
  • Keywords
  • CellRapeutics™ Leukopak from Hypertension Donor, Leukopak, Hypertension

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Hypertension Donor (XS-0426-XU282). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.